Healthcare Realty Trust Incorporated

BOVESPA:H2TA34 Stock Report

Market Cap: R$36.1b

Healthcare Realty Trust Future Growth

Future criteria checks 0/6

Healthcare Realty Trust is forecast to grow earnings and revenue by 66% and 0.8% per annum respectively. EPS is expected to grow by 64.8% per annum. Return on equity is forecast to be -3.3% in 3 years.

Key information

66.0%

Earnings growth rate

64.8%

EPS growth rate

Health Care REITs earnings growth24.4%
Revenue growth rate0.8%
Future return on equity-3.3%
Analyst coverage

Good

Last updated19 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:H2TA34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,316-153N/AN/A3
12/31/20251,259-140N/AN/A7
12/31/20241,250-554N/AN/A7
9/30/20241,288-595230491N/A
6/30/20241,314-570235490N/A
3/31/20241,336-507286507N/A
12/31/20231,342-282269500N/A
9/30/20231,351-276296519N/A
6/30/20231,315-179201413N/A
3/31/20231,122-9198298N/A
12/31/202293238109273N/A
9/30/20227299660189N/A
6/30/202256066137241N/A
3/31/202254683130234N/A
12/31/202153465132233N/A
9/30/202152327128229N/A
6/30/202151237379470N/A
3/31/202150490382474N/A
12/31/202049970376470N/A
9/30/2020495113385466N/A
6/30/2020490108150228N/A
3/31/202048237142217N/A
12/31/201947037148213N/A
9/30/201946226159216N/A
6/30/201945530138202N/A
3/31/201945163137202N/A
12/31/201845067138208N/A
9/30/201844514113201N/A
6/30/201843811N/A193N/A
3/31/2018432-2N/A191N/A
12/31/201742521N/A180N/A
9/30/2017422111N/A178N/A
6/30/2017419120N/A176N/A
3/31/2017416108N/A157N/A
12/31/201641286N/A151N/A
9/30/201640553N/A149N/A
6/30/201639858N/A152N/A
3/31/201639263N/A167N/A
12/31/201538859N/A154N/A
9/30/201538549N/A161N/A
6/30/201538240N/A142N/A
3/31/201537731N/A134N/A
12/31/201437134N/A125N/A
9/30/201436234N/A127N/A
6/30/201435130N/A128N/A
3/31/2014341-7N/A126N/A
12/31/2013331-13N/A121N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: H2TA34 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: H2TA34 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: H2TA34 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: H2TA34's revenue (0.8% per year) is forecast to grow slower than the BR market (7.5% per year).

High Growth Revenue: H2TA34's revenue (0.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: H2TA34 is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y